Guus van Dalum Selected Research

Carcinoma (Carcinomatosis)

1/2020	Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells.
1/2014	Detection of circulating tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guus van Dalum Research Topics

Disease

4	Circulating Neoplastic Cells 01/2020 - 07/2015
4	Neoplasms (Cancer) 10/2019 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2014
2	Prostatic Neoplasms (Prostate Cancer) 04/2018 - 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 10/2019

Drug/Important Bio-Agent (IBA)

3	Epithelial Cell Adhesion MoleculeIBA 01/2020 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2019
1	AntibodiesIBA 01/2020
1	Complement System Proteins (Complement)IBA 10/2019
1	Circulating MicroRNAIBA 10/2019
1	Circulating Tumor DNAIBA 10/2019
1	MicroRNAs (MicroRNA)IBA 10/2019
1	Keratin-18 (Keratin 18)IBA 04/2018
1	CaspasesIBA 04/2018

Therapy/Procedure

4	Therapeutics 10/2019 - 01/2014
1	Castration 04/2018
1	Radiotherapy 01/2015